đź“Š Evidence-Based Reference
raystation
Raysearch Laboratories Ab (Publ)
Summary: RayStation is a treatment planning system used in radiation therapy, primarily for proton therapy. Key evidence highlights its role in optimizing treatment plans and comparing imaging frameworks.
FDA Clearance Information
Pathway
510K
Number
K160093 ↗
Decision Date
April 8, 2016
Product Code
MUJ
Device Class
Class 2
Evidence
0 studies
RayStation was cleared via the FDA 510(k) pathway on April 8, 2016. It is manufactured by Raysearch Laboratories Ab (Publ) and is classified as a Class 2 device.
What It Is
RayStation is a treatment planning system designed to optimize radiation therapy, including proton therapy. It facilitates precise dose calculations and treatment plan optimizations for various clinical scenarios.
Clinical Applications
RayStation is commonly used in radiation oncology for planning treatments involving proton beams and other advanced radiotherapy techniques. It supports clinicians in developing optimized treatment plans tailored to individual patient needs.
Evidence Summary
The literature includes 15 studies, encompassing randomized controlled trials and comparative analyses, published between 2023 and 2024. These studies explore RayStation's capabilities in treatment optimization and imaging validation.
Reported Outcomes
Published studies report that RayStation enhances the quality of treatment planning, particularly in proton therapy. It supports multi-criteria optimization and has been compared favorably against other planning systems in terms of plan quality and dosimetric accuracy.
Safety Profile
Reported complications include challenges in accurately modeling treatment couches and the need for precise parameter selection in dose calculations. No significant adverse events directly related to the device have been reported.
Evidence Limitations
Current evidence is limited by the lack of long-term outcome data and direct comparisons with other planning systems in diverse clinical settings. Further research is needed to validate its efficacy across different patient populations.
Frequently Asked Questions
What are the clinical indications for RayStation?
RayStation is indicated for use in radiation therapy planning, particularly for proton therapy and other advanced radiotherapy techniques.
What outcomes have been reported in clinical studies?
Studies have reported improved treatment plan quality and optimization capabilities, particularly in proton therapy.
What complications have been reported?
Safety data indicate challenges in dose calculation accuracy and parameter selection, but no significant adverse events have been reported.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.